The human gene map for performance and health-related fitness phenotypes: The 2004 update

Medicine and Science in Sports and Exercise

Volumn 37, Issue 6, 2005, Pages 881-903

  Wolfarth, Bernd ^a   Bray, Molly S ^b   Hagberg, James M ^c   Perusse, Louis ^d   Rauramaa, Rainer ^e,f   Rivera, Miguel A ^g   Roth, Stephen M ^c   Rankinen, Tuomo ^h   Bouchard, Claude ^h  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIVERSITÉ LAVAL   (Canada)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^h PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Candidate genes; Genetic variants; Genetics; Linkage; Mitochondrial genome; Nuclear genome; Quantitative trait loci

Indexed keywords

AUTOSOME; CONTROLLED STUDY; FITNESS; GENE LOCUS; GENE MAPPING; GENE TECHNOLOGY; GENETIC VARIABILITY; HEALTH CARE ACCESS; HUMAN; MITOCHONDRIAL GENETICS; PEER REVIEW; PHENOTYPE; PHYSICAL PERFORMANCE; QUANTITATIVE TRAIT LOCUS; REVIEW; SITTING; X CHROMOSOME;

ANTHROPOMETRY; ARRHYTHMIA; CASE-CONTROL STUDIES; EXERCISE; GENOME, HUMAN; GLUCOSE; HEMODYNAMIC PROCESSES; HEMOSTASIS; HUMANS; INSULIN; LINKAGE (GENETICS); LIPIDS; PHENOTYPE; PHYSICAL ENDURANCE; PHYSICAL FITNESS; SPORTS; UNITED STATES;

EID: 20544441894     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.mss.0000168663.55604.1d     Document Type: Review

References (222)

1. ABRAHAM, M. R., L. J. OLSON, and M. J. JOYNER. Angiotensin- convertingenzyme genotype modulates pulmonary function and exercise capacity in treatedpatients with congestive stable heart failure. Circulation 106:1794-1799, 2002.
2. ALVAREZ, R., N. TERRADOS, and R. ORTOLANO. Genetic variation in the renin-angiotensin system and athletic performance. Eur. J. Appl. Physiol. 82:117-120, 2000.
3. ANDREU, A. L., C. BRUNO, and T. C. DUNNE. A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann. Neurol. 45:127-130, 1999.
4. ANDREU, A. L., C. BRUNO, and S. SHANSKE. Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. Neurology 51:1444-1447, 1998.
5. ANDREU, A. L., M. G. HANNA, and H. REICHMANN. Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N. Engl. J. Med. 341:1037-1044, 1999.
6. ANDREU, A. L., K. TANJI, and C. BRUNO. Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann. Neurol. 45:820-823, 1999.
7. BERNSTEIN, M. S., M. C. COSTANZA, and R. W. JAMES. Physical activity may modulate effects of ApoE genotype on lipid profile. Arterioscler. Thromb. Vasc. Biol. 22:133-140, 2002.
8. BLANCHET, C., Y. GIGUERE, D. PRUD'HOMME, M. DUMONT, F. ROUSSEAU, and S. DODIN. Association of physical activity and bone: influence of vitamin D receptor genotype. Med. Sci. Sports Exerc. 34:24-31, 2002.
9. BOER, J. M., J. A. KUIVENHOVEN, and E. J. FESKENS. Physical activity modulates the effect of a lipoprotein lipase mutation (D9N) on plasma lipids and lipoproteins. Clin. Genet. 56:158-163, 1999.
10. BOUCHARD, C., T. RANKINEN, and Y. C. CHAGNON. Genomic scan for maximal oxygen uptake and its response to training in the HERITAGE Family Study. J. Appl. Physiol. 88:551-559, 2000.
11. BRULL, D., S. DHAMRAIT, and S. MYERSON. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet 358:1155-1156, 2001.
12. BRULL, D. J., S. DHAMRAIT, and R. MOULDING. The effect of fibrinogen genotype on fibrinogen levels after strenuous physical exercise. Thromb. Haemost. 87:37-41, 2002.
13. BRULL, D. J., N. SERRANO, and F. ZITO. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 23:2063-2069, 2003.
14. BRUNO, C., G. MANFREDI, and A. L. ANDREU. A splice junction mutation in the alpha(M) gene of phosphorylase kinase in a patient with myopathy. Biochem. Biophys. Res. Commun. 249: 648-651, 1998.
15. BRUNO, C., F. M. SANTORELLI, and S. ASSERETO. Progressive exercise intolerance associated with a new muscle-restricted non-sense mutation (0142X) in the mitochondrial cytochrome b gene. Muscle Nerve 28:508-511, 2003.
16. BUEMANN, B., B. SCHIERNING, and S. TOUBRO. The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency. Int. J. Obes. Relat. Metab. Disord. 25:467-471, 2001.
17. CAMPOS, Y., J. BAUTISTA, and E. GUTIERREZ-RIVAS. Clinical heterogeneity in two pedigrees with the 3243 bp tRNA(Leu(UUR)) mutation of mitochondrial DNA. Acta Neurol. Scand. 91:62-65, 1995.
18. CAMPOS, Y., A. GARCIA, and A. LOPEZ. Cosegregation of the mitochondrial DNA A1555G and G4309A mutations results in deafness and mitochondrial myopathy. Muscle Nerve 25:185-188, 2002.
19. CHAGNON, Y. C., T. RICE, and L. PERUSSE. Oenomic scan for genes affecting body composition before and after training in Caucasians from HERITAGE. J. Appl. Physiol. 90:1777-1787, 2001.
20. COLLINS, M., S. L. XENOPHONTOS, and M. A. CARIOLOU. The ACE gene and endurance performance during the South African Ironman Triathlons. Med. Sci. Sports Exerc. 36:1314-1320, 2004.
21. COMI, G. P., F. FORTUNATO, and S. LUCCHIARI. Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis. Ann. Neurol. 50:202-207, 2001.
22. CORBALAN, M. S. The 27Glu polymorphism of the beta2-adrenergic receptor gene interacts with physical activity influencing obesity risk among female subjects. Clin. Genet. 61:305-307, 2002.
23. CORELLA D., M. GUILLEN, and C. SAIZ. Environmental factors modulate the effect of the APOE genetic polymorphism on plasma lipid concentrations: ecogenetic studies in a Mediterranean Spanish population. Metabolism 50:936-944, 2001.
24. DATA, S. A., M. H. ROLTSCH, B. HAND, R. E. FERRELL, J. J. PARK, and M. D. BROWN. eNOS T-786C genotype, physical activity, and peak forearm blood flow in females. Med. Sci. Sports. Exerc. 35:1991-1997, 2003.
25. DE GROOTE, P., N. HELBECQUE, and N. LAMBLIN. Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure. Eur. J. Heart Fail. 6:17-21, 2004.
26. DELANGHE, J., M. LANGLOIS, D. DUPREZ, M. DE BUYZERE, and D. CLEMENT. Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145:287-292, 1999.
27. DENGEL, D. R., M. D. BROWN, R. E. FERRELL, T. H. REYNOLDS IV, and M. A. SUPIANO. Exercise-induced changes in insulin action are associated with ACE gene polymorphisms in older adults. Physiol. Genomics 11:73-80, 2002.
28. DENNIS, R. A., T. A. TRAPPE, and P. SIMPSON. Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise. J. Physiol. 560:617-626, 2004.
29. DHAMRAIT, S. S., L. JAMES, and D. J. BRULL. Cortical bone resorption during exercise is interleukin-6 genotype-dependent. Eur. J. Appl. Physiol. 89:21-25, 2003.
30. 2max, and response to endurance training. Med. Sci. Sports Exerc. 23:177-185, 1991.
31. EISENACH, J. H., A. M. MCGUIRE, R. M. SCHWINGLER, S. T. TURNER, and M. J. JOYNER. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. Physiol. Genomics 16:323-328. 2004.
32. ERBS, S., Y. BAITHER, and A. LINKE. Promoter but not exon 7 polymorphism of endothelial nitric oxide synthase affects training-induced correction of endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 23:1814-1819, 2003.
33. FATINI, C., R. GUAZZELLI, and P. MANETTI. RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study. Med. Sci. Sports Exerc. 32:1868-1872, 2000.
34. FOLLAND, J., B. LEACH, and T. LITTLE. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp. Physiol. 85:575-579, 2000.
35. FRANKS, P. W., I. BARROSO, and J. LUAN. PGC-1alpha genotype modifies the association of volitional energy expenditure with [OV0312]O2max. Med. Sci. Sports Exerc. 35:1998-2004, 2003.
36. FRANKS, P. W., S. BHATTACHARYYA, and J. LUAN. Association between physical activity and blood pressure is modified by variants in the G-protein coupled receptor 10. Hypertension 43:224-228, 2004.
37. FRIEDL, W., F. KREMPLER, F. SANDHOFER, and B. PAULWEBER. Insertion/deletion polymorphism in the angiotensin-converting-enzyme gene and blood pressure during ergometry in normal males. Clin. Genet. 50:541-544, 1996.
38. FRIEDL, W., J. MAIR, M. PICHLER, B. PAULWEBER, F. SANDHOFER, and B. PUSCHENDORF. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene is associated with atrial natriuretic peptide activity after exercise. Clin. Chim. Acta 274: 199-211, 1998.
39. GAINETDINOV, R. R., W. C. WETSEL, S. R. JONES, E. D. LEVIN, M. JABER, and M. G. CARON. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401, 1999.
40. GARENC, C., L. PERUSSE, and J. BERCERON. Evidence of LPL gene-exercise interaction for body fat and LPL activity: the HERITAGE Family Study. J. Appl. Physiol. 91:1334-1340, 2001.
41. GARENC, C., L. PERUSSE, and Y. C. CHAGNON. Effects of beta2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study. Obes. Res. 11:612-618, 2003.
42. GAYACAY, G., B. YU, and B. HAMBLY. Elite endurance athletes and the ACE I allele-the role of genes in athletic performance. Hum. Genet. 103:48-50, 1998.
43. GEUSENS, P., C. VANDEVYVER, J. VANHOOF, J. J. CASSIMAN, S. BOONEN, and J. RAUS. Quadriceps and grip strength are related to vitamin D receptor genotype in elderly nonobese women. J. Bone Miner. Res. 12:2082-2088, 1997.
44. GHIU, I. A., R. E. FERRELL, O. KULAPUTANA, D. A. PHARES, and J. M. HAGBERG. Selected genetic polymorphisms and plasma coagulation factor VII changes with exercise training. J. Appl. Physiol 96:985-990, 2004.
45. GOSKER, H. R., H. J. PENNINGS, and A. M. SCHOLS. ACE Gene Polymorphism in COPD. Am. J. Respir. Crit. Care Med. 170: 572; author reply 572-573, 2004.
46. GRAFAKOU, O., F. A. HOL, and K. OTFRIED SCHWAB. Exercise intolerance, muscle pain and lactic acidaemia associated with a 7497G>A mutation in the tRNASer(UCN) gene. J. Inherit. Metab. Dis. 26:593-600, 2003.
47. GRUNDBERG, E., H. BRANDSTROM, E. L. RIBOM, O. LJUNGGREN, H. MALLMIN, and A. KINDMARK. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur. J. Endocrinol. 150: 323-328, 2004.
48. GRUNIO, E., B. JANSSEN, and D. MERELES. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 102:1145-1150. 2000.
49. HADJIGEORGIOU, G. M., N. KAWASHIMA, and C. BRUNO. Manifesting heterozygotes in a Japanese family with a novel mutation in the muscle-specific phosphoglycerate mutase (PGAM-M) gene. Neuromuscul. Disord. 9:399-402, 1999.
50. HAGBERG, J. M., R. E. FERRELL, D. R. DENGEL, and K. R. WILUND. Exercise training-induced blood pressure and plasma lipid improvements in hypertensives may be genotype dependent. Hypertension 34:18-23, 1999.
51. HAGBERG, J. M., R. E. FERRELL, L. I. KATZEL, D. R. DENGEL, J. D. SORKIN, and A. P. GOLDBERG. Apolipoprotein E genotype and exercise training-induced increases in plasma high-density lipoprotein (HDL)- and HDL2-cholesterol levels in overweight men. Metabolism 48:943-945, 1999.
52. 2max is associated with ACE genotype in postmenopausal women. J. Appl. Physiol. 85:1842-1846, 1998.
53. HAGBERG, J. M., S. D. MCCOLE, and M. D. BROWN. ACE insertion/deletion polymorphism and submaximal exercise hemodynamics in postmenopausal women. J. Appl. Physiol. 92:1083-1088, 2002.
54. HALVERSTADT, A., D. A. PHARES, R. E. FERRELL, K. R. WILUND, A. P. GOLDBERG, and J. M. HAGBERG. High-density lipoprotein-cholesterol, its subfractions, responses to exercise training are dependent on endothelial lipase genotype. Metabolism 52:1505-1511, 2003.
55. HANNA, M. G., I. P. NELSON, and S. RAHMAN. Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. Am. J. Hum. Genet. 63:29-36, 1998.
56. HAO, H., E. BONILLA, G. MANFREDI, S. DIMAURO, and C. T. MORAES. Segregation patterns of a novel mutation in the mitochondrial tRNA glutamic acid gene associated with myopathy and diabetes mellitus. Am. J. Hum. Genet. 56:1017-1025, 1995.
57. HELED, Y., D. S. MORAN, L. MENDEL, A. LAOR, E. PRAS, and Y. SHAPIRO. Human ACE I/D polymorphism is associated with individual differences in exercise heat tolerance. J. Appl. Physiol. 97:72-76, 2004.
58. HELLERUD, C., N. WRAMNER, A. ERIKSON, A. JOHANSSON, G. SAMUELSON, and S. LINDSTEDT. Glycerol kinase deficiency: follow-up during 20 years, genetics, biochemistry and prognosis. Acta Paediatr. 93:911-921, 2004.
59. HOPKINSON, N. S., A. H. NICKOL, and J. PAYNE. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 170:395-399, 2004.
60. HUDSON, D. E., G. G. MOKONE, T. D. NOAKES, and M. COLLINS. The -55 C/T polymorphism within the UCP3 gene and performance during the South African Ironman Triathlon. Int. J. Sports Med. 25:427-432, 2004.
61. HUYGENS, W., M. A. THOMIS, and M. W. PEETERS. Linkage of myostatin pathway genes with knee strength in humans. Physiol. Genomics 17:264-270, 2004.
62. HUYGENS, W., M. A. THOMIS, and M. W. PEETERS. A quantitative trait locus on 13q14.2 for trunk strength. Twin Res. 7:603-606, 2004.
63. IVEY, F. M., S. M. ROTH, and R. E. FERRELL. Effects of age, gender, myostatin genotype on the hypertrophic response to heavy resistance strength training. J. Gerontol. A. Biol. Sci. Med. Sci. 55:M641-648, 2000.
64. JAMSHIDI, Y., H. E. MONTGOMERY, and H. W. HENSE. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension. Circulation 105:950-955, 2002.
65. KAHARA, T., T. HAYAKAWA, Y., NAGAI, A. SHIMIZU, and T. TAKAMURA. Gln27Glu polymorphism of the beta2 adrenergic receptor gene in healthy Japanese men is associated with the change of fructosamine level caused by exercise. Diabetes Res. Clin. Pract. 64:207-212, 2004.
66. KAHARA, T., T. TAKAMURA, and T. HAYAKAWA. PPARgamma gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men. Metabolism 52:209-212, 2003.
67. KAHARA, T., T. TAKAMURA, and T. HAYAKAWA. Prediction of exercise-mediated changes in metabolic markers by gene polymorphism. Diabetes Res. Clin. Pract. 57:105-110, 2002.
68. KALLIO, J., U. PESONEN, and K. KAIPIO. Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans. FASEB J. 15:1242-1244, 2001.
69. KALLIO, J., U. PESONEN, and M. K. KARVONEN. Enhanced exercise-induced GH secretion in subjects with Pro7 substitution in the prepro-NPY. J. Clin. Endocrinol. Metab. 86: 5348-5352, 2001.
70. KANAZAWA, H., K. HIRATA, and J. YOSHIKAWA. Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study. Thorax 58:629-631, 2003.
71. KANAZAWA, H., K. HIRATA, and J. YOSHIKAWA. Influence of oxygen administration on pulmonary haemodynamics and tissue oxygenation during exercise in COPD patients with different ACE genotypes. Clin. Phvsiol. Fund. Imaging. 23:332-336, 2003.
72. KANAZAWA, H., T. OKAMOTO, K. HIRATA, and J. YOSHIKAWA. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162:1235-1238, 2000.
73. KANAZAWA, H., T. OTSUKA, K. HIRATA, and J. YOSHIKAWA. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 121:697-701, 2002.
74. KANAZAWA, H., Y. TATEISHI, and J. YOSHIKAWA. Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms. Clin. Physiol. Funct. Imaging. 24:224-228, 2004.
75. KARADIMAS, C. L., P. GREENSTEIN, and C. M. SUE. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA. Neurology 55:644-649, 2000.
76. KARADIMAS, C. L., L. SALVIATI, and S. SACCONI. Mitochondrial myopathy and ophthalmoplegia in a sporadic patient with the G12315A mutation in mitochondrial DNA. Neuromuscul. Disord. 12:865-868, 2002.
77. KEIGHTLEY, J. A., R. ANITORI, M. D. BURTON, F. QUAN, N. R. BUIST, and N. G. KENNAWAY. Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene. Am. J. Hum. Genet. 67:1400-1410, 2000.
78. KELLY, M. A., M. RUBINSTEIN, and T. J. PHILLIPS. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, developmental adaptations. J. Neurosci. 18:3470-3479, 1998.
79. KIMURA, T., T. YOKOYAMA, and Y. MATSUMURA. NOS3 genotype-dependent correlation between blood pressure and physical activity. Hypertension 41:355-360, 2003.
80. KITAGAWA, I., Y. KITAGAWA, T. NAGAYA, and S. TOKUDOME. Interplay of physical activity and vitamin D receptor gene polymorphism on bone mineral density. J. Epidemiol. 11:229-232, 2001.
81. KRIZANOVA, O., J. KOSKA, M. VIGAS, and R. KVETNANSKY. Correlation of M235T DNA polymorphism with cardiovascular and endocrine responses during physical exercise in healthy subjects. Physiol. Res. 47:81-88, 1998.
82. LAHAT, H., M. ELDAR, and E. LEVY-NISSENBAUM. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 103:2822-2827, 2001.
83. LAHAT, H., E. PRAS, and T. OLENDER. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am. J. Hum. Genet. 69:1378-1384, 2001.
84. LAITINEN, P. J., K. M. BROWN, and K. PUPPO. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103:485-490, 2001.
85. LAKKA, T. A. T. RANKINEN, and S. J. WEISNAGEL. Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: the HERITAGE family study. Diabetes 53:1603-1608, 2004.
86. LAKKA, T. A., T. RANKINEN, and S. J. WEISNAGEL. A quantitative trait locus on 7q31 for the changes in plasma insulin in response to exercise training: the HERITAGE Family Study. Diabetes 52:1583-1587, 2003.
87. LAMANTEA, E., F. CARRARA, C. MARIOTTI, L. MORANDI, V. TIRANTI, and M. ZEVIANI. A novel nonsense mutation (Q352X) in the mitochondrial cytochrome b gene associated with a combined deficiency of complexes I and III. Neuromuscul. Disord. 12:49-52, 2002.
88. LANOUETTE, C. M., Y. C. CHAGNON, and T. RICE. Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study. J Appl. Physiol 92:1111-1118, 2002.
89. LEON, A. S., K. TOGASHI, and T. RANKINEN. Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE family study. Metabolism 53:108-116, 2004.
90. LINDI, V. I., M. I. UUSITUPA, and J. LINDSTROM. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51:2581-2586, 2002.
91. LORENTZON, M., R. LORENTZON, U. H. LERNER, and P. NORDSTROM. Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Eur. J. Endocrinol. 144:257-261, 2001.
92. LORENTZON, M., R. LORENTZON, and P. NORDSTROM. Vitamin D receptor gene polymorphism is related to bone density, circulating osteocalcin, parathyroid hormone in healthy adolescent girls. J. Bone Miner. Metab. 19:302-307, 2001.
93. MACHO-AZCARATE, T., J. CALABUIG, A. MARTI, and J. A. MARTINEZ. A maximal effort trial in obese women carrying the beta2-adrenoceptor Gln27Glu polymorphism. J. Physiol. Biochem. 58: 103-108, 2002.
94. MACHO-AZCARATE, T., A. MARTI, J. CALABUIG, and J. A. MARTINEZ. Basal fat oxidation and after a peak oxygen consumption test in obese women with a beta2 adrenoceptor gene polymorphism. J. Nutr. Biochem. 14:275-279, 2003.
95. MACHO-AZCARATE, T., A. MARTI, A. GONZALEZ, J. A. MARTINEZ, and J. IBANEZ. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. Int. J. Obes. Relat. Metab. Disord. 26:1434-1441, 2002.
96. MANCUSO, M., M. FILOSTO, and J. C. STEVENS. Mitochondrial myopathy and complex III deficiency in a patient with a new stop-codon mutation (G339X) in the cytochrome b gene. J. Neurol. Sci. 209:61-63, 2003.
97. MARTIN, M. A., J. C. RUBIO, and P. DEL HOYO. Identification of novel mutations in Spanish patients with muscle carnitine palmitoyltransferase II deficiency. Hum. Mutat. 15:579-580, 2000.
98. MCCOLE, S. D., M. D. BROWN, and G. E. MOORE. Angiotensinogen M235T polymorphism associates with exercise hemodynamics in postmenopausal women. Physiol. Genomics. 10:63-69, 2002.
99. MCCOLE, S. D., A. R. SHULDINER, and M. D. BROWN. Beta2- and beta3-adrenergic receptor polymorphisms and exercise hemodynamics in postmenopausal women. J. Appl. Physiol. 96:526-530, 2004.
100. MCFARLAND, R., R. W. TAYLOR, P. F. CHINNERY, N. HOWELL, and D. M. TURNBULL. A novel sporadic mutation in cytochrome c oxidase subunit II as a cause of rhabdomyolysis. Neuromuscul. Disord. 14:162-166, 2004.
101. MCKENZIE, J. A., E. P. WEISS, and I. A. GHIU. Influence of the interleukin-6-174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indexes. J. Appl. Physiol. 97:1338-1342, 2004.
102. MEIRHAEGHE, A., N. HELBECQUE, D. COTTEL, and P. AMOUYEL. Beta2-adrenoceptor gene polymorphism, body weight, physical activity. Lancet 353:896, 1999.
103. MEIRHAEGHE, A., J. LUAN, and P. SELBERG-FRANKS. The effect of the Gly 16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity. J. Clin. Endocrinol. Metab. 86:5881-5887, 2001.
104. MONGINI, T., C. DORIGUZZI, I. BOSONE, L. CHIADO-PIAT, E. P. HOFFMAN, and L. PALMUCCI. Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuria. Neuropediatrics 33:109-111, 2002.
105. MONTGOMERY, H., P. CLARKSON, and M. BARNARD. Angiotensin-converting- enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 353:541-545, 1999.
106. MONTGOMERY, H. E., P. CLARKSON, and C. M. DOLLERY. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741-747, 1997.
107. MONTGOMERY, H. E., P. CLARKSON, and O. M. NWOSE. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene. Arterioscler. Thromb. Vasc. Biol. 16:386-391, 1996.
108. MONTGOMERY, H. E., R. MARSHALL, and H. HEMINGWAY. Human gene for physical performance. Nature 393:221-222, 1998.
109. MOORE, G. E., A. R. SHULDINER, J. M. ZMUDA, R. E. FERRELL, S. D. MCCOLE, and JM. HAGBERG. Obesity gene variant and elite endurance performance. Metabolism 50:1391-1392, 2001.
110. MOOREN, F. C., and K. VOLKER. MOLECULAR AND CELLULAR EXERCISE PHYSIOLOGY. CHAMPAIGN, IL: HUMAN KINETICS, 2005.
111. MUKHERJEE, M., and K. R. SHETTY. Variations in high-density lipoprotein cholesterol in relation to physical activity and Taq 1B polymorphism of the cholesteryl ester transfer protein gene. Clin. Genet. 65:412-418, 2004.
112. MUNOZ-MALAGA, A., J. BAUTISTA, and J. A. SALAZAR. Lipomatosis, proximal myopathy, the mitochondrial 8344 mutation. A lipid storage myopathy? Muscle Nerve 23:538-542, 2000.
113. MUSUMECI, O., A. L. ANDREU, and S. SHANSKE. Intragenic Inversion of mtDNA: A New Type of Pathogenic Mutation in a Patient with Mitochondrial Myopathy. Am. J. Hum. Genet. 66:1900-1904, 2000.
114. MYERSON, S., H. HEMINGWAY, R. BUDGET, J. MARTIN, S. HUMPHRIES, and H. MONTGOMERY. Human angiotensin I-converting enzyme gene and endurance performance. J. Appl. Physiol. 87:1313-1316, 1999.
115. MYERSON, S. G., H. E. MONTGOMERY, and M. WHITTINGHAM. Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan. Circulation 103:226-230, 2001.
116. NAKAMURA, O., T. ISHII, and Y. ANDO. Potential role of vitamin D receptor gene polymorphism in determining bone phenotype in young male athletes. J. Appl. Physiol. 93:1973-1979, 2002.
117. NAZAROV, I. B., D. R. WOODS, and H. E. MONTGOMERY. The angiotensin converting enzyme I/D polymorphism in Russian athletes. Eur. J. Hum. Genet. 9:797-801, 2001.
118. OBISESAN, T. O., C. LEEUWENBURGH, and T. PHILLIPS. C-reactive protein genotypes affect baseline, but not exercise training-induced changes, in C-reactive protein levels. Arterioscler. Thromb. Vasc. Biol. 24:1874-1879, 2004.
119. ORTLEPP, J. R., J. METRIKAT, M. ALBRECHT, A. VON KORFF, P. HANRATH, and R. HOFFMANN. The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet. Med. 20:451-454, 2003.
120. ORTLEPP, J. R., J. METRIKAT, and K. VESPER. The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, monocyte counts and reduced physical fitness in young healthy smokers. J. Mol Med. 81:578-584, 2003.
121. OSBORNE, K. A., A. ROBICHON, and E. BURGESS. Natural behavior polymorphism due to a cGMP-dependent protein kinase of Drosophila. Science 277:834-836, 1997.
122. OTABE, S., K. CLEMENT, and C. DINA. A genetic variation in the 5′ flanking region of the UCP3 gene is associated with body mass index in humans in interaction with physical activity. Diabetologia 43:245-249, 2000.
123. PANTOJA-MARTINEZ, J., C. NAVARRO FERNANDEZ-BALBUENA, M. GORMAZ-MORENO, B. QUINTANS-CASTRO, M. A. ESPARZA-SANCHEZ, and J. BONET-ARZO. Myoadenylate deaminase deficiency in a child with myalgias induced by physical exercise. Rev. Neurol. 39:431-434, 2004.
124. PATEL, S., D. R. WOODS, and N. J. MACLEOD. Angiotensin-converting enzyme genotype and the ventilatory response to exertional hypoxia. Eur. Respir. J. 22:755-760, 2003.
125. PERUSSE, L., T. RANKINEN, and A. ZUBERI. The human obesity gene map: the 2004 update. Obes. Res. (In press), 2005.
126. PETERS, W. R., J. P. MACMURRY, J. WALKER, R. J. GIESE, JR., and D. E. COMINGS. Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women. Obes. Res. 11:415-419, 2003.
127. PHARES, D. A., A. A. HALVERSTADT, and A. R. SHULDINER. Association between body fat response to exercise training and multilocus ADR genotypes. Obes. Res. 12:807-815, 2004.
128. PISCIOTTA, L., A. CANTAFORA, and A. PIANA. Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. Nutr. Metab. Cardiovasc. Dis. 13:202-210, 2003.
129. POSTMA, A. V., I. DENJOY, and T. M. HOORNTJE. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 91:e21-26, 2002.
130. PRIOR, S. J., J. M. HAGBERG, and D. A. PHARES. Sequence variation in hypoxia-inducible factor 1alpha (HIF1A): association with maximal oxygen consumption. Physiol. Genomics 15:20-26, 2003.
131. PRIORI, S. G., C. NAPOLITANO, and N. TISO. Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation 103:196-200, 2001.
132. PULKES, T., A. SIDDIQUI, J. A. MORGAN-HUGHES, and M. G. HANNA. A novel mutation in the mitochondrial tRNA(TYr) gene associated with exercise intolerance. Neurology 55:1210-1212, 2000.
133. RANKINEN, T., P. AN, and L. PERUSSE. Genome-wide linkage scan for exercise stroke volume and cardiac output in the HERITAGE Family Study. Physiol. Genomics 10:57-62, 2002.
134. RANKINEN, T., P. AN, and T. RICE. Genomic scan for exercise blood pressure in the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Hypertension 38:30-37, 2001.
135. RANKINEN, T., J. GAGNON, and L. PERUSSE. AGT M235T and ACE ID polymorphisms and exercise blood pressure in the HERITAGE Family Study. Am. J. Physiol. Heart Circ. Physiol. 279: H368-374, 2000.
136. RANKINEN, T. L. PERUSSE, and I. BORECKI. The Na(+)-K(+)-ATPase alpha2 gene and trainability of cardiorespiratory endurance: the HERITAGE family study. J. Appl. Physiol. 88:346-351, 2000.
137. RANKINEN, T., L. PERUSSE, and J. GAGNON. Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study. J. Appl. Physiol. 88:1029-1035, 2000.
138. RANKINEN, T., L. PERUSSE, R. RAURAMAA, M. A. RIVERA, B. WOLFARTH, and C. BOUCHARD. The human gene map for performance and health-related fitness phenotypes. Med. Sci. Sports Exerc. 33:855-867, 2001.
139. RANKINEN, T., L. PERUSSE, R. RAURAMAA, M. A. RIVERA, B. WOLFARTH, and C. BOUCHARD. The human gene map for performance and health-related fitness phenotypes: the 2003 update. Med. Sci. Sports Exerc. 36:1451-1469, 2004.
140. RANKINEN, T., T. RICE, and A. BOUDREAU. Titin is a candidate gene for stroke volume response to endurance training: the HERITAGE Family Study. Physiol. Genomics 15:27-33, 2003.
141. RANKINEN, T., T. RICE, and A. S. LEON. G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol. Genomics 8:151-157, 2002.
142. RANKINEN, T., T. RICE, and L. PERUSSE. NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study. Hypertension 36:885-889, 2000.
143. RAURAMAA, R., R. KUHANEN, and T. A. LAKKA. Physical exercise and blood pressure with reference to the angiotensinogen M235T polymorphism. Physiol. Genomics 10:71-77, 2002.
144. RAURAMAA, R., S. VAISANEN, and A. NISSINEN. Physical activity, fibrinogen plasma level and gene polymorphisms in postmenopausal women. Thromb. Haemost. 78:840-844, 1997.
145. RAURAMAA, R., S. B. VAISANEN, R. KUHANEN, I. PENTTILA, and C. BOUCHARD. The RsaI polymorphism in the alpha-fibrinogen gene and response of plasma fibrinogen to physical training-a controlled randomised clinical trial in men. Thromb. Haemost. 83: 803-806, 2000.
146. REMES, T., S. B. VAISANEN, and A. MAHONEN. Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, estrogen receptor alpha gene polymorphisms. Bone 32:412-420, 2003.
147. RICE, T., Y. C. CHAGNON, and L. PERUSSE. A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes 51: 848-855, 2002.
148. RICE, T., T. RANKINEN, and Y. C. CHAGNON. Genomewide linkage scan of resting blood pressure: HERITAGE Family Study. Health, Risk Factors, Exercise Training, Genetics. Hypertension 39:1037-1043, 2002.
149. RICO-SANZ, J., T. RANKINEN, and D. R. JOANISSE. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family Study. Physiol. Genomics 14:161-166, 2003.
150. RICO-SANZ, J., T. RANKINEN, and T. RICE. Quantitative trait loci for maximal exercise capacity phenotypes and their responses to training in the HERITAGE Family Study. Physiol. Genomics 16:256-260, 2004.
151. RIECHMAN, S. E., G. BALASEKARAN, S. M. ROTH, and R. E. FERRELL. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J. Appl. Physiol. 97:2214-2219, 2004.
152. RIECHMAN, S. E., T. J. FABIAN, P. D. KROBOTH, and R. E. FERRELL. Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET. Physiol. Genomics 17:300-306, 2004.
153. 2max in the HERITAGE Family Study. Med. Sci. Sports Exerc. 29:1311-1317, 1997.
154. RIVERA, M. A., M. ECHEGARAY, and T. RANKINEN. Angiogenin gene-race interaction for resting and exercise BP phenotypes: the HERITAGE Family Study. J. Appl. Physiol. 90:1232-1238, 2001.
155. RIVERA, M. A., M. ECHEGARAY, and T. RANKINEN. TGF-beta(1) gene-race interactions for resting and exercise blood pressure in the HERITAGE Family Study. J. Appl. Physiol. 91:1808-1813, 2001.
156. 2max in the HERITAGE Family Study. Med. Sci. Sports Exerc. 31:698-701, 1999.
157. RODAS, G., G. ERCILLA, and C. JAVIERRE. Could the A2A11 human leucocyte antigen locus correlate with maximal aerobic power? Clin. Sci. (Colch). 92:331-333, 1997.
158. ROTH, S. M., E. J. METTER, M. R. LEE, B. F. HURLEY, and R. E. FERRELL. C174T polymorphism in the CNTF receptor gene is associated with fat-free mass in men and women. J. Appl. Physiol. 95:1425-1430, 2003.
159. ROTH, S. M., M. A. SCHRAGER, and R. E. FERRELL. CNTF genotype is associated with muscular strength and quality in humans across the adult age span. J. Appl. Physiol. 90:1205-1210, 2001.
160. ROTH, S. M., J. M. ZMUDA, J. A. CAULEY, P. R. SHEA, and R. E. FERRELL.
161. SAKANE, N., T. YOSHIDA, T. UMEKAWA, A. KOGURE, Y. TAKAKURA, and M. KONDO. Effects of Trp64Arg mutation in the beta 3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, insulin resistance in obese type 2 diabetic patients. Diabetes Care 20:1887-1890, 1997.
162. SALMEN, T., A. M. HEIKKINEN, and A. MAHONEN. Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, fracture risk in early postmenopausal women. Ann. Med. 35:282-288, 2003.
163. SAYER, A. A., H. SYDDALL, and S. D. O'DELL. Polymorphism of the IGF2 gene, birth weight and grip strength in adult men. Age Ageing 31:468-470, 2002.
164. SCANAVINI, D., F. BERNARDI, E. CASTOLDI, F. CONCONI, and G. MAZZONI. Increased frequency of the homozygous II ACE genotype in Italian Olympic endurance athletes. Eur. J. Hum. Genet. 10:576-577, 2002.
165. SCHOLTE, H. R., R. N. VAN COSTER, and P. C. DE JONGE. Myopathy in very-long-chain acyl-CoA dehydrogenase deficiency: clinical and biochemical differences with the fatal cardiac phenotype. Neuromuscul. Disord. 9:313-319, 1999.
166. SCHRAGER, M. A., S. M. ROTH, and R. E. FERRELL. Insulin-like growth factor-2 (IGF2) genotype, fat-free mass, muscle performance across the adult life span. J. Appl. Physiol. 97:2176-2183, 2004.
167. SCHUELKE, M., H. KRUDE, and B. FINCKH. Septo-optic dysplasia associated with a new mitochondrial cytochrome b mutation. Ann. Neurol. 51:388-392, 2002.
168. SCHWARTZ, P. J., S. G. PRIORI, and C. SPAZZOLINI. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103:89-95, 2001.
169. SEIBERT, M. J., Q. L. XUE, L. P. FRIED, and J. D. WALSTON. Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II cohort. J. Am. Geriatr. Soc. 49:1093-1096, 2001.
170. SELVADURAI, H. C., K. O. MCKAY, C. J. BLIMKIE, P. J. COOPER, C. M. MELLIS, and P. P. VAN ASPEREN. The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:762-765, 2002.
171. SENGLER, C., A. HEINZMANN, and S. P. JERKIC. Clara cell protein 16 (CC16) gene polymorphism influences the degree of airway responsiveness in asthmatic children. J. Allergy Clin. Immunol. 111:515-519, 2003.
172. SENTI, M., C. AUBO, R. ELOSUA, J. SALA, M. TOMAS, and J. MARRUGAT. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene. Genet. Epidemiol. 18:276-286, 2000.
173. SHERMAN, J. B., N. RABEN, and C. NICASTRI. Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII-and their population frequency. Am. J. Hum. Genet. 55:305-313, 1994.
174. SHIWAKU, K., A. NOGI, and E. ANUURAD. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. Int. J. Obes. Relat. Metab. Disord. 27:1028-1036, 2003.
175. SIMONEN, R. L., T. RANKINEN, and L. PERUSSE. A dopamine D2 receptor gene polymorphism and physical activity in two family studies. Physiol Behav. 78:751-757, 2003.
176. SIMONEN, R. L., T. RANKINEN, and L. PERUSSE. Genome-wide linkage scan for physical activity levels in the Quebec Family study. Med. Sci. Sports Exerc. 35:1355-1359, 2003.
177. SLATTERY, M. L., M. MURTAUGH, B. CAAN, K. N. MA, R. WOLFF, and W. SAMOWITZ. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control 15: 863-872, 2004.
178. STEFAN, N., B. VOZAROVA, and A. DEL PARIGI. The Gln223Arg polymorphism of the leptin receptor in Pima Indians: influence on energy expenditure, physical activity and lipid metabolism. Int. J. Obes. Relat. Metab. Disord. 26:1629-1632, 2002.
179. SUN, G., J. GAGNON, and Y. C. CHAGNON. Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int. J. Obes. Relat. Metab. Disord. 23:929-935, 1999.
180. TAGGART, R. T., D. SMAIL, C. APOLITO, and G. D. VLADUTIU. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum. Mutat. 13:210-220, 1999.
181. TAIMELA, S., T. LEHTIMAKI, K. V. PORKKA, L. RASANEN, and J. S. VIIKARI. The effect of physical activity on serum total and low-density lipoprotein cholesterol concentrations varies with apolipoprotein E phenotype in male children and young adults: The Cardiovascular Risk in Young Finns Study. Metabolism 45:797-803, 1996.
182. TAJIMA, O., N, ASHIZAWA, and T. ISHII. Interaction of the effects between vitamin D receptor polymorphism and exercise training on bone metabolism. J. Appl. Physiol. 88:1271-1276, 2000.
183. TARONI, F., E. VERDERIO, F. DWORZAK, P. J. WILLEMS, P. CAVADINI, and S. DIDONATO. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nat. Genet. 4:314-320, 1993.
184. THOMIS, M. A., W. HUYGENS, and S. HEUNINCKX. Exploration of myostatin polymorphisms and the angiotensin-converting enzyme insertion/deletion genotype in responses of human muscle to strength training. Eur. J. Appl. Physiol. 92:267-274, 2004.
185. THOMPSON, P. D., G. J. TSONGALIS, and R. L. SEIP. Apolipoprotein E genotype and changes in serum lipids and maximal oxygen uptake with exercise training. Metabolism 53:193-202, 2004.
186. TIRET, L., O. POIRIER, and V. HALLET. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 33:1169-1174, 1999.
187. TODOROVA, B., A. KUBASZEK, and J. PIHLAJAMAKI. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. J. Clin. Endocrinol. Metab. 89:2019-2023, 2004.
188. TOMAS, M., R. ELOSUA, and M. SENTI. Paraoxonasel-192 polymorphism modulates the effects of regular and acute exercise on paraoxonasel activity. J. Lipid Res. 43:713-720, 2002.
189. TOSCANO, A., S. TSUJINO, G. VITA, S. SHANSKE, C. MESSINA, and S. DIMAURO. Molecular basis of muscle phosphoglycerate mutase (PGAM-M) deficiency in the Italian kindred. Muscle Nerve 19: 1134-1137, 1996.
190. TSUJINO, S., S. SERVIDEI, P. TONIN, S. SHANSKE, G. AZAN, and S. DIMAURO. Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am. J. Hum. Genet. 54:812-819, 1994.
191. TSUJINO, S., S. SHANSKE, A. K. BROWNELL, R. G. HALLER, and S. DIMAURO. Molecular genetic studies of muscle lactate dehydrogenase deficiency in white patients. Ann. Neurol. 36:661-665, 1994.
192. TSUJINO, S., S. SHANSKE, and S. DIMAURO. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N. Engl. J. Med. 329:241-245, 1993.
193. TSUJINO, S., S. SHANSKE, and S. DIMAURO. Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency. Muscle Nerve 3:S45-49, 1995.
194. TSUJINO, S., S. SHANSKE, S. SAKODA, G. FENICHEL, and S. DIMAURO. The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency. Am. J. Hum. Genet. 52:472-477, 1993.
195. TSURITANI, I., K. S. BROOKE-WAVELL, S. S. MASTANA, P. R. JONES, A. E. HARDMAN, and Y. YAMADA. Does vitamin D receptor polymorphism influence the response of bone to brisk walking in postmenopausal women? Horm. Res. 50:315-319, 1998.
196. TURGUT, G., S. TURGUT, O. GENC, A. ATALAY, and E. O. ATALAY. The angiotensin converting enzyme I/D polymorphism in Turkish athletes and sedentary controls. Acta Medica (Hradec Kralove). 47:133-136, 2004.
197. TWOROGER, S. S., J. CHUBAK, and E. J. AIELLO. The effect of CYP19 and COMT polymorphisms on exercise-induced fat loss in postmenopausal women. Obes. Res. 12:972-981, 2004.
198. VAISANEN, S. B., S. E. HUMPHRIES, L. A. LUONG, I. PENTTILA, C. BOUCHARD, and R. RAURAMAA. Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G/5G promoter polymorphism in the PAI-1 gene. Thromb. Haemost. 82:1117-1120, 1999.
199. VAN POTTELBERGH, I., S. GOEMAERE, L. NUYTINCK, A. DE PAEPE, and J. M. KAUFMAN. Association of the type I collagen alpha1 Sp1 polymorphism, bone density and upper limb muscle strength in community-dwelling elderly men. Osteoporos. Int. 12:895-901, 2001.
200. VAN ROSSUM, E. F., P. G. VOORHOEVE, and S. J. TE VELDE. The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab. 89:4004-4009, 2004.
201. VERMEER, S., A. VERRIPS, M. A. WILLEMSEN, H. J. TER LAAK, I. B. GINJAAR, and B. C. HAMEL. Novel mutations in three patients with LGMD2C with phenotypic differences. Pediatr. Neurol. 30:291-294, 2004.
202. VISSING, J., M. B. SALAMON, and P. ARLIEN-SOBORG. A new mitochondrial tRNA(Met) gene mutation in a patient with dystrophic muscle and exercise intolerance. Neurology 50:1875-1878, 1998.
203. VIVES-BAUZA, C., J. GAMEZ, and M. ROIG. Exercise intolerance resulting from a muscle-restricted mutation in the mitochondrial tRNA(Leu (CUN)) gene. Ann. Med. 33:493-496, 2001.
204. VLADUTIU, G. D., M. J. BENNETT, and N. M. FISHER. Phenotypic variability among first-degree relatives with carnitine palmitoyltransferase II deficiency. Muscle Nerve 26:492-498, 2002.
205. VLADUTIU, G. D., M. J. BENNETT, D. SMAIL, L. J. WONG, R. T. TAGGART, and H. B. LINDSLEY. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene. Mol. Genet. Metab. 70:134-141, 2000.
206. VORGERD, M., J. KARTTZKY, and M. RISTOW. Muscle phosphofructokinase deficiency in two generations. J. Neurol. Sci. 141:95-99, 1996.
207. WAGONER, L. E., L. L. CRAFT, and B. SINGH. Polymorphisms of the beta(2)-adrenergic receptor determine exercise capacity in patients with heart failure. Circ. Res. 86:834-840, 2000.
208. WAGONER, L. E., L. L. CRAFT, and P. ZENGEL. Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure. Am. Heart J. 144:840-846, 2002.
209. WANG, Q., M. E. CURRAN, and I. SPLAWSKI. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12:17-23, 1996.
210. WILLIAMS, A. G., S. S. DHAMRAIT, and P. T. WOOTTON. Bradykinin receptor gene variant and human physical performance. J. Appl. Physiol. 96:938-942, 2004.
211. WILLIAMS, A. G., M. P. RAYSON, and M. JUBB. The ACE gene and muscle performance. Nature 403:614, 2000.
212. WILUND, K. R., R. E. FERRELL, D. A. PHARES, A. P. GOLDBERG, and J. M. HAGBERG. Changes in high-density lipoprotein-cholesterol subfractions with exercise training may be dependent on cholesteryl ester transfer protein (CETP) genotype. Metabolism 51: 774-778, 2002.
213. WINNICKI, M., V. ACCURSO, and M. HOFFMANN. Physical activity and angiotensin-converting enzyme gene polymorphism in mild hypertensives. Am. J. Med. Genet. A. 125:38-44, 2004.
214. WOLFARTH, B., M. A. RIVERA, and J. M. OPPERT. A polymorphism in the alpha2a-adrenoceptor gene and endurance athlete status. Med. Sci. Sports Exerc. 32:1709-1712, 2000.
215. WOO, S. K., and H. S. KANG. Apolipoprotein C-III SstI genotypes modulate exercise-induced hypotriglyceridemia. Med. Sci. Sports Exerc. 36:955-959, 2004.
216. WOODS, D., M. HICKMAN, and Y. JAMSHIDI. Elite swimmers and the D allele of the ACE I/D polymorphism. Hum. Genet. 108: 230-232, 2001.
217. WOODS, D., G. ONAMBELE, and R. WOLEDGE. Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J. Clin. Endocrinol. Metab. 86:2200-2204, 2001.
218. WOODS, D., J. SANDERS, and A. JONES. The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, the influence of ACE genotype. Eur. J. Appl. Physiol. 91:342-348, 2004.
219. WOODS, D. R., M. WORLD, and M. P. RAYSON. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training. Eur. J. Appl. Physiol. 86:240-244, 2002.
220. YANG, N., D. G. MACARTHUR, and J. P. GULBIN. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 73:627-631, 2003.
221. ZHANG, B., T. SAKAI, and S. MIURA. Association of angiotensin-converting- enzyme gene polymorphism with the depressor response to mild exercise therapy in patients with mild to moderate essential hypertension. Clin. Genet. 62:328-333, 2002.
222. 2max) of Chinese males. Life Sci. 73:2625-2630, 2003.